Table of contents
March 2011 - Volume 70 - Suppl 2
31st European Workshop for Rheumatology Research March 3–6, 2011 in Amsterdam, The Netherlands
- Introduction
- 1. The earliest stages of immune-mediated inflammatory disease
- 2. Gene regulation and signaling
- 3. Stromal cells and fibrosis
- 4. Myeloid cells and innate immune receptors
- 5. Decision making in the T-cell immune system
- 6. Lymphocytes, lymphoid cells and ectopic lymphoid structures
- 7. The role of B cells in inflammatory diseases
- 8. Towards novel therapeutic strategies
- 9. Other topics
- 10. ACR Fellows
- Author index
Introduction
- Introduction (22 February, 2011)
1. The earliest stages of immune-mediated inflammatory disease
- Caspase-1 is active since the early phase of rheumatoid arthritis (22 February, 2011)
- Rheumatoid arthritis: involvement of the synovium in the preclinical phase? (22 February, 2011)
- Formation of gouty tophi is initiated by extranuclear DNA (22 February, 2011)
- CRP discriminates primary from secondary necrosis (22 February, 2011)
- Naïve T cells predict MTX induced remission in early arthritis (22 February, 2011)
- New autoantibodies associated with early rheumatoid arthritis (22 February, 2011)
- Lung changes are present in ACPA positive RA patients already at disease onset (22 February, 2011)
2. Gene regulation and signaling
- Interleukin 33 expression in human arthritis (22 February, 2011)
- HLA-DRB1*04 is a novel fetal susceptibility allele in congenital heart block (22 February, 2011)
- Genetic variants of C1q are a risk for rheumatoid arthritis (22 February, 2011)
- Loss of NPP1 induces cartilage remodelling into bone and OA-like changes in mice (22 February, 2011)
- MAPK-activated protein kinase-2 regulates physiological bone turnover (22 February, 2011)
- The type 1 interferon signature: facts, fads and fallacies (22 February, 2011)
3. Stromal cells and fibrosis
- Triggering of viral RNA sensors induces CD55 expression on synovial fibroblasts (22 February, 2011)
- S100A8/A9 in bleomycin-induced skin fibrosis (22 February, 2011)
- PTPN22 R620W may affect age at onset and survival of SSC patients (22 February, 2011)
- TIMP-1 production by monocytes may contribute to SSc skin fibrosis (22 February, 2011)
4. Myeloid cells and innate immune receptors
- Involvement of toll-like receptor 2 in pristane-induced lupus (22 February, 2011)
- Chromatin-activated neutrophils represent a major source of interferon α (22 February, 2011)
- A20 (TNFAIP3) deficiency in myeloid cells triggers rheumatoid arthritis (22 February, 2011)
- Regulation of autoimmune inflammation by myeloid-derived suppressor cells (22 February, 2011)
- Identifying the TLR4 bearing target cell in experimental arthritis (22 February, 2011)
5. Decision making in the T-cell immune system
- Inhibition of miR-182 decreases OVA-induced arthritis in mice (22 February, 2011)
- The involvement of Neuropilin-1 and immune Semaphorin's in lupus nephritis (22 February, 2011)
- Implication of IDO in RA patients treated by biologics (22 February, 2011)
6. Lymphocytes, lymphoid cells and ectopic lymphoid structures
- Breakage of B cell tolerance by antigens on follicular dendritic cells (22 February, 2011)
7. The role of B cells in inflammatory diseases
- Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy (22 February, 2011)
- Impaired B cell immunity in IL-22 knock-out mice in collagen induced arthritis (22 February, 2011)
- Impaired regulatory capacities of B lymphocytes in systemic lupus erytematosus (22 February, 2011)
- Fc-glycosylation of IgG1 is modulated by B cell Stimuli (22 February, 2011)
- Epratuzumab affects B cells trafficking in systemic lupus erythematosus (22 February, 2011)
8. Towards novel therapeutic strategies
- CD4 T cells producing IL-10 have a beneficial effect in murine lupus (22 February, 2011)
- Myostatin – a new player in inflammatory bone loss (22 February, 2011)
- TNFα and chemerin cross-talk in rheumatoid arthritis (22 February, 2011)
- Interstitial lung disease in patients with scleroderma: treatment with rituximab (22 February, 2011)
- Micro-RNA 155 controls the pathogenesis of autoimmune arthritis (22 February, 2011)
- Class effects of tyrosine kinase inhibitors on osteoclastogenesis in vitro (22 February, 2011)
9. Other topics
- Genetic interaction in the susceptibility of rheumatoid arthritis (22 February, 2011)
- Anti-MIT3 antibodies in systemic sclerosis (22 February, 2011)
- Potential role of S100A4 in an immune response of rheumatoid arthritis (22 February, 2011)
- Longitudinal immunomonitoring following tocilizumab in rheumatoid arthritis (22 February, 2011)
- Skewed X chromosome inactivation in rheumatoid arthritis women (22 February, 2011)
- PPARβ regulates bone-metabolism by facilitating Wnt-signalling (22 February, 2011)
- Role of syndecan-4 in chondrocyte differentiation (22 February, 2011)
- Study on autoimmune mechanisms in the neurological process (22 February, 2011)
10. ACR Fellows
- Regulation of VLA-4 in lupus monocytes objectives (22 February, 2011)